UNSPSC 51172476: Magaldrate/simethicone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA199. This VA Drug Class (GA199) classifies this compound as belonging to the group ANTACIDS, OTHER.

UNSPSC 51172476 Magaldrate/simethicone is a Commodity code that in recent state and local procurement activity covers antacid and gastrointestinal relief products supplied as part of broader pharmaceutical procurement programs rather than as standalone specialty items. State and local governments procure this code primarily through cooperative purchasing vehicles and health agencies managing multi-source generic pharmaceutical inventories for institutional, correctional, and public health populations. The issuing bodies span state health and human services commissions, county correction departments, and multistate cooperative purchasing alliances; Texas Health and Human Services Commission and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) appear as active buyers in the current cycle.

Recent activity concentrates in Texas and Minnesota. The Texas Health and Human Services Commission posted an RFI on March 27, 2026 (response deadline April 3, 2026) exploring direct-to-manufacturer prescription programs that would encompass generic pharmaceuticals including antacids within a broader therapeutic pharmacy initiative. MMCAP, administered by the Minnesota Department of Administration, issued an RFP on January 20, 2026 (response deadline March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products effective July 1, 2026, with contract terms of two years plus optional extensions; the RFP requires vendors to supply through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), maintain cGMP and DSCSA compliance, and accept a 3 percent administrative fee with pricing weighted at 75 percent of evaluation. Collin County's Community Supervision and Corrections Department issued an RFP (2026-327, response deadline July 23, 2026) for offender drug testing services with an estimated contract value of $600,000 and a two-year term commencing September 1, 2026, though this solicitation centers on specimen collection and testing rather than pharmaceutical supply.